APPENDIX 4.
Age | Plan | Second-Generation Macrolide Rate/Person-Year | First-Generation Cephalosporin Rate/Person-Year | Second-Generation Cephalosporin Rate/Person-Year | Third-Generation Cephalosporin Rate/Person-Year | ||||
---|---|---|---|---|---|---|---|---|---|
2000–2001 | 2009–2010 | 2000–2001 | 2009–2010 | 2000–2001 | 2009–2010 | 2000–2001 | 2009–2010 | ||
3 to <24 mo | |||||||||
A | 0.27 | 0.23 | 0.05 | 0.04 | 0.11 | 0.06 | 0.08 | 0.13 | |
B | 0.09 | 0.05 | 0.05 | 0.04 | 0.11 | NAa | 0.01 | 0.15 | |
C | 0.34 | 0.30 | 0.05 | 0.05 | 0.25 | 0.07 | 0.04 | 0.22 | |
2 to <4 years | |||||||||
A | 0.24 | 0.23 | 0.06 | 0.06 | 0.06 | 0.03 | 0.04 | 0.07 | |
B | 0.06 | 0.06 | 0.05 | 0.05 | 0.04 | NAa | 0.01 | 0.08 | |
C | 0.22 | 0.23 | 0.06 | 0.05 | 0.12 | 0.04 | 0.01 | 0.11 | |
4 to <6 y | |||||||||
A | 0.20 | 0.23 | 0.06 | 0.07 | 0.05 | 0.03 | 0.03 | 0.05 | |
B | 0.05 | 0.05 | 0.05 | 0.05 | 0.02 | NAa | NAa | 0.04 | |
C | 0.16 | 0.21 | 0.06 | 0.05 | 0.08 | 0.03 | 0.01 | 0.07 | |
6 to <12 y | |||||||||
A | 0.13 | 0.16 | 0.06 | 0.08 | 0.03 | 0.02 | 0.01 | 0.02 | |
B | 0.03 | 0.05 | 0.04 | 0.04 | 0.01 | NAa | NAa | 0.01 | |
C | 0.11 | 0.16 | 0.06 | 0.05 | 0.04 | 0.02 | NAa | 0.03 | |
12 to <18 y | |||||||||
A | 0.11 | 0.14 | 0.07 | 0.08 | 0.02 | 0.01 | NAa | 0.01 | |
B | 0.03 | 0.06 | 0.05 | 0.04 | 0.01 | 0.01 | NAa | NAa | |
C | 0.08 | 0.13 | 0.06 | 0.06 | 0.02 | 0.02 | NAa | 0.01 |
All changes from 2000–2001 to 2009–2010 were statistically significant (p <0.001). NA, not applicable.
Antibiotic rate <0.01 dispensing per person-year.